Trial intelligence / Profile preview

Pasipay (Passiflora incarnata) for minor depressive disorder

IRCT20141227020441N8Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Feb 2020
Countries
1
01

Overview

Phase 3 trial of passiflora incarnata in major depressive disorder (MDD), sponsored by Shiraz University of Medical Sciences. Started Feb 2020; status: completed.

02

Drugs

passiflora incarnata
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT20141227020441N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141227020441N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call